Portfolio Holdings Detail for ISIN IE0009QS7W62
| Stock Name / Fund | iShares MSCI World Health Care Sector ESG UCITS ETF USD (Acc) |
| Issuer | |
| Entity holding fund | iShares V Public Limited Company |
| Entity Type | |
| Entity LEI | 549300QETNU1W5JY7Z94 |
| ETF Ticker | WHCA(EUR) Euronext Amsterdam |
Holdings detail for ABBV
| Stock Name | AbbVie Inc |
| Ticker | ABBV(USD) NYSE |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US00287Y1091 |
| LEI | FR5LCKFTG8054YNNRU85 |
Show aggregate ABBV holdings
News associated with ABBV
- Boost Your Portfolio With These Top-Ranked ETFs
- With the Fed's first 2025 rate cut and upgraded growth outlook, ETFs in tech, financials, industrials and health care could benefit from momentum. - 2025-09-19 13:03:00
- AbbVie (NYSE:ABBV) Reaches New 12-Month High After Analyst Upgrade
- AbbVie Inc. (NYSE:ABBV – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Thursday after Berenberg Bank upgraded the stock from a hold rating to a buy rating. Berenberg Bank now has a $270.00 price target on the stock, up from their previous price target of $170.00. AbbVie traded as […] - 2025-09-19 03:10:53
- AbbVie (NYSE:ABBV) Upgraded by Berenberg Bank to Buy Rating
- AbbVie (NYSE:ABBV – Get Free Report) was upgraded by investment analysts at Berenberg Bank from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Wednesday, Marketbeat reports. The firm currently has a $270.00 price target on the stock, up from their previous price target of $170.00. Berenberg […] - 2025-09-19 02:24:45
- Noteworthy Thursday Option Activity: ZS, CRM, ABBV
- Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Zscaler Inc (Symbol: ZS), where a total of 10,858 contracts have traded so far, representing approximately 1.1 million underlying shares. That amounts to about 58.1% of - 2025-09-18 16:21:04
- Notable ETF Inflow Detected - ITOT, HD, ABBV, AMD
- Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core S&P Total U.S. Stock Market ETF (Symbol: ITOT) where we have detected an approximate $179.9 million dollar inflow -- that's a 0.2% i - 2025-09-18 13:25:16
- Guru Fundamental Report for ABBV
- Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our Multi-Factor Investor model based on the published strategy of Pim van Vliet. This multi-factor model seeks low volatility stocks that also have st - 2025-09-18 10:39:12
- AbbVie (NYSE:ABBV) Trading Up 1.8% on Analyst Upgrade
- AbbVie Inc. (NYSE:ABBV – Get Free Report) shares rose 1.8% on Wednesday after Berenberg Bank upgraded the stock from a hold rating to a buy rating. Berenberg Bank now has a $270.00 price target on the stock, up from their previous price target of $170.00. AbbVie traded as high as $221.55 and last traded at […] - 2025-09-18 03:08:42
- ABBV Factor-Based Stock Analysis
- Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-09-17 10:34:46
- AbbVie (NYSE:ABBV) Price Target Raised to $245.00
- AbbVie (NYSE:ABBV – Get Free Report) had its target price boosted by equities researchers at Cantor Fitzgerald from $215.00 to $245.00 in a research note issued to investors on Monday, MarketBeat reports. The brokerage currently has an “overweight” rating on the stock. Cantor Fitzgerald’s price objective points to a potential upside of 13.28% from the […] - 2025-09-17 02:56:46
- ABBV Quantitative Stock Analysis
- Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-09-16 10:32:29
- Validea Detailed Fundamental Analysis - ABBV
- Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-09-12 10:32:52
- Company News for Sep 12, 2025
- Companies in The News Are: TSLA, WBD, DOW, ABBV - 2025-09-12 10:18:00
- The Best Stocks to Invest $50,000 In Right Now
- Key PointsAbbVie is a Dividend King that's proven its resilience. - 2025-09-12 05:46:00
- Notable Thursday Option Activity: ABBV, LRCX, UAL
- Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in AbbVie Inc (Symbol: ABBV), where a total volume of 26,476 contracts has been traded thus far today, a contract volume which is representative of approximately 2.6 - 2025-09-11 14:43:20
- Noteworthy ETF Inflows: VONG, ABBV, HD, RCL
- Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard Russell 1000 Growth ETF (Symbol: VONG) where we have detected an approximate $454.7 million dollar inflow -- that's a 1.4% increase week ove - 2025-09-10 11:51:17
- ABBV Factor-Based Stock Analysis
- Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-09-10 10:34:13
- Daily Dividend Report: VZ,ESS,AVGO,SACH,ABBV,NUE
- The Board of Directors at Verizon Communications today declared a quarterly dividend of 69 cents per outstanding share, an increase of 1.25 cents per share from the previous quarter. The quarterly dividend is payable on November 3, 2025 to Verizon shareholders of record at the c - 2025-09-05 12:59:15
- Guru Fundamental Report for ABBV
- Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-09-04 10:32:24
- Validea Detailed Fundamental Analysis - ABBV
- Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-08-29 10:33:22
- ABBV Factor-Based Stock Analysis
- Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-08-27 10:34:48
- As the Market Rotates, This Healthcare ETF Is Leading the Way
- Over the past month, the market has undergone a rotation that’s seen tech sell-off and defensive sectors like healthcare reap the rewards. The jury remains out on whether this shift indicates a more inclusive rally or if it should raise questions about the bull market’s footing. - 2025-08-26 10:35:00
- ABBV Quantitative Stock Analysis
- Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-08-26 10:34:00
- Noteworthy ETF Inflows: SSO, ABBV, BAC, KO
- Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ProShares Ultra S&P500 (Symbol: SSO) where we have detected an approximate $147.7 million dollar inflow -- that's a 2.1% increase week over week - 2025-08-25 13:36:49
- Validea Detailed Fundamental Analysis - ABBV
- Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-08-22 10:34:21
- ABBV Factor-Based Stock Analysis
- Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-08-20 10:33:59
- Noteworthy ETF Outflows: ACWI, ABBV, BAC, KO
- Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares MSCI ACWI ETF (Symbol: ACWI) where we have detected an approximate $160.0 million dollar outflow -- that's a 0.7% decrease week over week (f - 2025-08-15 11:48:20
- Validea Detailed Fundamental Analysis - ABBV
- Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-08-15 10:31:59
- 3 Dividend Stocks to Double Up On Right Now
- Key PointsAbbVie is a Dividend King with an especially attractive valuation. - 2025-08-15 05:53:00
- ABBV Quantitative Stock Analysis
- Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-08-12 10:33:16
- 4 of My Favorite Dividend Stocks for the Next 5 Years
- My favorite type of dividend stock to invest in is dividend growth stocks. I like companies that pay safe, reliable, and growing dividends. I care less about yield and more about dividend growth. - 2025-08-09 10:42:00
iShares MSCI World Health Care Sector ESG UCITS ETF USD (Acc) ABBV holdings
| Date | Number of ABBV Shares Held | Base Market Value of ABBV Shares | Local Market Value of ABBV Shares | Change in ABBV Shares Held | Change in ABBV Base Value | Current Price per ABBV Share Held | Previous Price per ABBV Share Held |
|---|
| 2025-11-27 (Thursday) | 144,167 | USD 32,821,059 | USD 32,821,059 | 0 | USD 0 | USD 227.66 | USD 227.66 |
| 2025-11-26 (Wednesday) | 144,167 | USD 32,821,059 | USD 32,821,059 | 0 | USD -596,852 | USD 227.66 | USD 231.8 |
| 2025-11-25 (Tuesday) | 144,167 | USD 33,417,911 | USD 33,417,911 | 0 | USD 330,143 | USD 231.8 | USD 229.51 |
| 2025-11-24 (Monday) | 144,167 | USD 33,087,768 | USD 33,087,768 | 16,968 | USD 3,033,188 | USD 229.51 | USD 236.28 |
| 2025-11-21 (Friday) | 127,199 | USD 30,054,580 | USD 30,054,580 | 0 | USD 868,769 | USD 236.28 | USD 229.45 |
| 2025-11-20 (Thursday) | 127,199 | USD 29,185,811 | USD 29,185,811 | 1,501 | USD -90,510 | USD 229.45 | USD 232.91 |
| 2025-11-19 (Wednesday) | 125,698 | USD 29,276,321 | USD 29,276,321 | 0 | USD -120,670 | USD 232.91 | USD 233.87 |
| 2025-11-18 (Tuesday) | 125,698 | USD 29,396,991 | USD 29,396,991 | 0 | USD -16,341 | USD 233.87 | USD 234 |
| 2025-11-17 (Monday) | 125,698 | USD 29,413,332 | USD 29,413,332 | 0 | USD 206,145 | USD 234 | USD 232.36 |
| 2025-11-14 (Friday) | 125,698 | USD 29,207,187 | USD 29,207,187 | 0 | USD 8,799 | USD 232.36 | USD 232.29 |
| 2025-11-13 (Thursday) | 125,698 | USD 29,198,388 | USD 29,198,388 | 0 | USD -118,157 | USD 232.29 | USD 233.23 |
| 2025-11-12 (Wednesday) | 125,698 | USD 29,316,545 | USD 29,316,545 | 0 | USD 1,013,126 | USD 233.23 | USD 225.17 |
| 2025-11-11 (Tuesday) | 125,698 | USD 28,303,419 | USD 28,303,419 | 0 | USD 812,009 | USD 225.17 | USD 218.71 |
| 2025-11-10 (Monday) | 125,698 | USD 27,491,410 | USD 27,491,410 | 0 | USD -56,564 | USD 218.71 | USD 219.16 |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of ABBV by for IE0009QS7W62
Show aggregate share trades of ABBV| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-11-24 | BUY | 16,968 | 237.566 | 228.500 | 229.407 | USD 3,892,571 | 201.31 |
| 2025-11-20 | BUY | 1,501 | 234.950 | 228.000 | 228.695 | USD 343,271 | 200.90 |
| 2025-11-05 | BUY | 3,002 | 217.430 | 212.600 | 213.083 | USD 639,675 | 198.87 |
| 2025-11-04 | BUY | 3,000 | 217.080 | 212.370 | 212.841 | USD 638,523 | 198.75 |
| 2025-10-29 | BUY | 1,502 | 225.140 | 228.000 | 227.714 | USD 342,026 | 198.11 |
| 2025-10-28 | BUY | 3,004 | 227.540 | 228.400 | 228.314 | USD 685,855 | 197.89 |
| 2025-10-20 | SELL | -1,502 | 232.060 | 232.260 | 232.240 | USD -348,824 | 196.44 Loss of -53,777 on sale |
| 2025-10-16 | BUY | 1,502 | 226.870 | 228.110 | 227.986 | USD 342,435 | 195.94 |
| 2025-10-07 | BUY | 2,998 | 232.830 | 234.080 | 233.955 | USD 701,397 | 195.14 |
| 2025-09-26 | BUY | 4,491 | 220.610 | 221.480 | 221.393 | USD 994,276 | 192.98 |
| 2025-08-26 | BUY | 3,296 | 208.360 | 208.580 | 208.558 | USD 687,407 | 190.91 |
| 2025-07-18 | BUY | 1,458 | 189.260 | 192.340 | 192.032 | USD 279,983 | 190.53 |
| 2025-07-11 | SELL | -1,458 | 192.450 | 194.000 | 193.845 | USD -282,626 | 190.53 Loss of -4,830 on sale |
| 2025-07-07 | SELL | -2,916 | 187.630 | 191.390 | 191.014 | USD -556,997 | 190.52 Loss of -1,436 on sale |
| 2025-06-17 | BUY | 1,458 | 185.480 | 190.610 | 190.097 | USD 277,161 | 191.31 |
| 2025-06-02 | SELL | -5,856 | 186.990 | 186.990 | 186.990 | USD -1,095,013 | 191.67 Profit of 27,380 on sale |
| 2025-05-30 | BUY | 33,979 | 186.110 | 186.690 | 186.632 | USD 6,341,569 | 191.76 |
| 2025-04-29 | BUY | 253 | 193.510 | 195.540 | 195.337 | USD 49,420 | 194.86 |
| 2025-03-25 | BUY | 1,052 | 201.340 | 209.260 | 208.468 | USD 219,308 | 212.64 |
| 2025-03-07 | SELL | -2,109 | 214.290 | 214.990 | 214.920 | USD -453,266 | 0.00 Loss of -453,266 on sale |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of ABBV
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-09-19 | 815,518 | 15,443 | 1,666,743 | 48.9% |
| 2025-09-18 | 976,224 | 2,478 | 1,754,400 | 55.6% |
| 2025-09-17 | 893,363 | 20 | 2,143,243 | 41.7% |
| 2025-09-16 | 560,813 | 445 | 1,384,147 | 40.5% |
| 2025-09-15 | 832,081 | 12,522 | 2,007,970 | 41.4% |
| 2025-09-12 | 690,879 | 1,041 | 1,419,503 | 48.7% |
| 2025-09-11 | 1,245,521 | 3,626 | 2,674,001 | 46.6% |
| 2025-09-10 | 926,048 | 1,636 | 1,760,143 | 52.6% |
| 2025-09-09 | 647,832 | 3,971 | 1,201,675 | 53.9% |
| 2025-09-08 | 977,496 | 669 | 1,948,911 | 50.2% |
| 2025-09-05 | 819,821 | 219 | 1,562,695 | 52.5% |
| 2025-09-04 | 656,683 | 16 | 1,245,755 | 52.7% |
| 2025-09-03 | 679,333 | 210 | 1,725,011 | 39.4% |
| 2025-09-02 | 571,491 | 426 | 1,368,661 | 41.8% |
| 2025-08-29 | 518,498 | 2,300 | 1,787,568 | 29.0% |
| 2025-08-28 | 512,260 | 362 | 1,422,956 | 36.0% |
| 2025-08-27 | 499,400 | 1,899 | 1,449,927 | 34.4% |
| 2025-08-26 | 475,100 | 950 | 932,729 | 50.9% |
| 2025-08-25 | 403,487 | 1,429 | 974,130 | 41.4% |
| 2025-08-22 | 670,583 | 1 | 1,671,946 | 40.1% |
| 2025-08-21 | 797,910 | 23,606 | 1,744,062 | 45.8% |
| 2025-08-20 | 674,508 | 1,957 | 2,202,738 | 30.6% |
| 2025-08-19 | 365,123 | 17,926 | 1,554,649 | 23.5% |
| 2025-08-18 | 847,966 | 8,427 | 2,576,315 | 32.9% |
| 2025-08-15 | 743,225 | 11,185 | 1,373,855 | 54.1% |
| 2025-08-14 | 1,018,839 | 1,076 | 1,755,746 | 58.0% |
| 2025-08-13 | 528,643 | 1,883 | 1,268,545 | 41.7% |
| 2025-08-12 | 462,405 | 2,349 | 1,254,915 | 36.8% |
| 2025-08-11 | 692,022 | 3,299 | 1,700,047 | 40.7% |
| 2025-08-08 | 556,303 | 200 | 1,659,046 | 33.5% |
| 2025-08-07 | 931,238 | 4,331 | 1,865,754 | 49.9% |
| 2025-08-06 | 736,384 | 304 | 1,460,024 | 50.4% |
| 2025-08-05 | 1,243,697 | 22,376 | 1,900,775 | 65.4% |
| 2025-08-04 | 874,215 | 42 | 1,689,343 | 51.7% |
| 2025-08-01 | 1,652,230 | 20,290 | 3,046,818 | 54.2% |
| 2025-07-31 | 1,890,893 | 13,627 | 3,855,820 | 49.0% |
| 2025-07-30 | 784,201 | 28 | 1,860,564 | 42.1% |
| 2025-07-29 | 955,470 | 195 | 1,973,297 | 48.4% |
| 2025-07-28 | 484,253 | 34 | 1,192,809 | 40.6% |
| 2025-07-25 | 540,340 | 276 | 1,401,474 | 38.6% |
| 2025-07-24 | 473,197 | 79 | 1,213,819 | 39.0% |
| 2025-07-23 | 693,240 | 1,214 | 1,535,061 | 45.2% |
| 2025-07-22 | 401,616 | 1,098 | 1,567,493 | 25.6% |
| 2025-07-21 | 792,579 | 22 | 1,928,371 | 41.1% |
| 2025-07-18 | 567,409 | 307 | 1,490,680 | 38.1% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Note: All information is provided as is without warranty and should be used for indicative purposes only.
You should independently check data before making any investment decision.
This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.